Natural course of restless legs syndrome/Willis–Ekbom disease: long-term observation of a large clinical cohort
- 1 October 2015
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 16 (10) , 1252-1258
Abstract
No abstract availableKeywords
Funding Information
- Translational Research Fund of the government of Tyrol Austria
This publication has 31 references indexed in Scilit:
- Long-term use of pramipexole in the management of restless legs syndromeSleep Medicine, 2012
- Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sampleSleep Medicine, 2011
- The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”)Sleep Medicine, 2009
- Augmentation as a treatment complication of restless legs syndrome: Concept and managementMovement Disorders, 2007
- Long‐term treatment with pramipexole in restless legs syndromeEuropean Journal of Neurology, 2006
- Restless legs syndrome augmentation associated with tramadolSleep Medicine, 2006
- Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care studySleep Medicine, 2004
- Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndromeSleep Medicine, 2003
- Restless legs syndrome: diagnostic criteria, special considerations, and epidemiologySleep Medicine, 2003
- Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset familiesAnnals of Neurology, 2002